Unknown

Dataset Information

0

Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men.


ABSTRACT: To evaluate whether genetic correction using the genetic variants prostate-specific antigen (PSA)-single nucleotide polymorphisms (SNPs) could reduce potentially unnecessary and/or delayed biopsies in African-American men.We compared the genotypes of four PSA-SNPs between 964 Caucasian and 363 African-American men without known prostate cancer (PCa). We adjusted the PSA values based on an individual's PSA-SNP carrier status, and calculated the percentage of men that would meet commonly used PSA thresholds for biopsy (? 2.5 or ? 4.0 ng/mL) before and after genetic correction. Potentially unnecessary and delayed biopsies were defined as those men who were below and above the biopsy threshold after genetic correction, respectively.Overall, 349 (96.1%) and 354 (97.5%) African-American men had measured PSA levels <2.5 and <4.0 ng/mL. Genetic correction in African-American men did not avoid any potentially unnecessary biopsies, but resulted in a significant (P < 0.001) reduction in potentially delayed biopsies by 2.5% and 3.9%, based on the biopsy threshold level.There are significant differences in the influence of the PSA-SNPs between African-American and Caucasian men without known PCa, as genetic correction resulted in an increased proportion of African-American men crossing the threshold for biopsy. These results raise the question of whether genetic differences in PSA might contribute to delayed PCa diagnosis in African-American men.

SUBMITTER: Donin NM 

PROVIDER: S-EPMC4326233 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men.

Donin Nicholas M NM   Loeb Stacy S   Cooper Phillip R PR   Roehl Kimberly A KA   Baumann Nikola A NA   Catalona William J WJ   Helfand Brian T BT  

BJU international 20140715 6b


<h4>Objective</h4>To evaluate whether genetic correction using the genetic variants prostate-specific antigen (PSA)-single nucleotide polymorphisms (SNPs) could reduce potentially unnecessary and/or delayed biopsies in African-American men.<h4>Subjects and methods</h4>We compared the genotypes of four PSA-SNPs between 964 Caucasian and 363 African-American men without known prostate cancer (PCa). We adjusted the PSA values based on an individual's PSA-SNP carrier status, and calculated the perce  ...[more]

Similar Datasets

2008-01-01 | GSE6956 | GEO
2008-06-15 | E-GEOD-6956 | biostudies-arrayexpress
2009-07-28 | GSE17356 | GEO
2013-01-31 | GSE41969 | GEO
2009-08-07 | E-GEOD-17356 | biostudies-arrayexpress
2013-01-31 | GSE41967 | GEO
| S-EPMC5839325 | biostudies-literature
2013-01-31 | E-GEOD-41967 | biostudies-arrayexpress
2013-01-31 | GSE41968 | GEO
| S-EPMC6040053 | biostudies-literature